Vivos Therapeutics Inc. (VVOS)
5.35
0.29 (5.73%)
At close: Jan 15, 2025, 11:08 AM
Company Description
Vivos Therapeutics, Inc., a medical technology company, develops and commercializes treatment alternatives for patients with dentofacial abnormalities, obstructive sleep apnea (OSA), and snoring in adults.
It offers the Vivos System, a non-invasive, non-surgical, non-pharmaceutical, multi-disciplinary treatment modality for the treatment of dentofacial abnormalities, OSA, and snoring.
Vivos Therapeutics also offers VivoScore Program, a screening and home sleep test in adults and children.
The company markets and sells its Vivos System to licensed professionals, primarily general dentists in the United States and Canada.
Vivos Therapeutics, Inc. was founded in 2016 and is based in Highlands Ranch, Colorado.
Vivos Therapeutics Inc.
| Country | United States |
| IPO Date | Dec 11, 2020 |
| Industry | Medical - Devices |
| Sector | Healthcare |
| Employees | 114 |
| CEO | R. Kirk Huntsman |
Contact Details
Address: 9137 Ridgeline Boulevard Highlands Ranch, Colorado United States | |
| Website | https://vivos.com |
Stock Details
| Ticker Symbol | VVOS |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001716166 |
| CUSIP Number | 92859E108 |
| ISIN Number | US92859E2072 |
| Employer ID | 81-3224056 |
| SIC Code | 3841 |
Key Executives
| Name | Position |
|---|---|
| R. Kirk Huntsman | Co-Founder, Chairman of the Board & Chief Executive Officer |
| Bradford K. Amman | Chief Financial Officer, Treasurer & Secretary |
| John Ballard | Senior Vice President of Technology |
| Nicholas M. DeGennaro | Senior Vice President of Medical Integration Division |
| RaeAnn Byrnes | Co-Founder and Senior Vice President of Events & Clinical Advisory Services |
| Ruth Hembree | Senior Vice President of Practice Services |
| Stephanie Huebner | Senior Vice President of Dental Service Integration |
| Susan McCullough | Co-Founder & Executive Vice President of Operations |
| Todd Huntsman | Co-Founder & Senior Vice President of Product and Technology |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Dec 30, 2024 | SCHEDULE 13G | Filing |
| Dec 26, 2024 | 424B5 | Filing |
| Dec 23, 2024 | 8-K | Current Report |
| Dec 20, 2024 | SCHEDULE 13G | Filing |
| Nov 27, 2024 | 8-K | Current Report |
| Nov 27, 2024 | 4 | Filing |
| Nov 27, 2024 | 4 | Filing |
| Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
| Nov 14, 2024 | 8-K | Current Report |
| Nov 14, 2024 | 10-Q | Quarterly Report |